BBB-permeable multiple tyrosine kinase inhibitors (ASINEX)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBBB-permeable multiple tyrosine kinase inhibitors (ASINEX)
Drug Alias Nameblood brain barrier-permieable multiple tyrosine kinase inhibitors (ASINEX)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine kinases inhibitors
TargetsProtein-tyrosine kinases
Therapy Area/IndicationsBrain Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesASINEX Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesASINEX Ltd
Active IndicationsN/A
Inactive IndicationsBrain Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A